Lymphocyte subsets as prognostic markers for cancer patients receiving immunomodulative therapy Micaela Hernberg Review 01 September 1999 Pages: 145 - 153
Micrometastatic bone marrow involvement: detection and prognostic significance S BraunK Pantel Review 01 September 1999 Pages: 154 - 165
The role of busulfan in bone marrow transplantation M Hassan Review 01 September 1999 Pages: 166 - 176
Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC) A NaglerR CondiottiLWMM Terstappen Review 01 September 1999 Pages: 177 - 187
A strategy for erythropoietin treatment in myelodysplastic syndromes R Hast Opinion 01 September 1999 Pages: 188 - 190
Topoisomerase II-mediated alterations of K562 drug resistant sublines R ZhouY WangE Liliemark Original Paper 01 September 1999 Pages: 191 - 198
The role of neoadjuvant and adjuvant chemotherapy regimens consisting of different combinations of drugs in the treatment of advanced oral cancer S BasuM KhanraP Chaudhuri Original Paper 01 September 1999 Pages: 199 - 203
The effect of two different doses of oral clodronate on pain in patients with bone metastases A AricanF İçliA Demirkazik Original Paper 01 September 1999 Pages: 204 - 210
Prevention of recurrence and prolonged survival in primary central nervous system lymphoma (PCNSL) patients treated with adjuvant high-dose methylprednisolone BP O’NeillTM HabermannM Rodriguez Original Paper 01 September 1999 Pages: 211 - 215
A case of resectable lung adenocarcinoma associated with sarcoidosis H YanagawaH GotoS Sone Case Report 01 September 1999 Pages: 216 - 220
Chimeric monoclonal anti-CD20 antibody (rituximab)—an effective treatment for a patient with relapsing hairy cell leukaemia H Hagberg Case Report 01 September 1999 Pages: 221 - 222
